What is the recommended management for an allergic reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Allergic Reactions

Epinephrine is the first-line treatment for anaphylaxis and should be administered immediately upon recognition of symptoms, with no absolute contraindications to its use in this life-threatening condition. 1, 2

Classification and Initial Management

Mild to Moderate Allergic Reactions

  • Symptoms: Flushing, urticaria, isolated mild angioedema, pruritus
  • Treatment:
    • H1 antihistamines (first-line for mild reactions)
      • Preferred: Second-generation (non-sedating) antihistamines like cetirizine, loratadine, or fexofenadine 3
      • Alternative: Diphenhydramine 1-2 mg/kg (maximum 50 mg) orally every 6 hours for 2-3 days 1
    • H2 antihistamines can be added (e.g., ranitidine twice daily for 2-3 days) 1
    • Important: Continuous monitoring is essential as mild reactions can progress to anaphylaxis 1

Severe Allergic Reactions/Anaphylaxis

  • Symptoms: Respiratory distress, hypotension, widespread urticaria, significant angioedema, laryngospasm, bronchospasm
  • Treatment:
    • First-line: Epinephrine IM 1, 2, 4
      • Weight 10-25 kg: 0.15 mg epinephrine autoinjector in anterior-lateral thigh
      • Weight >25 kg: 0.3 mg epinephrine autoinjector in anterior-lateral thigh
      • Alternative dosing: Epinephrine (1:1000 solution) 0.01 mg/kg IM, maximum 0.5 mg
      • May need to repeat doses every 5-15 minutes if symptoms persist

Adjunctive Treatments (Only After Epinephrine for Anaphylaxis)

  1. Bronchodilators (for bronchospasm)

    • Albuterol via MDI or nebulizer 1
  2. Antihistamines (not a substitute for epinephrine in anaphylaxis)

    • H1 antihistamines: Diphenhydramine or second-generation alternatives 1, 3
    • H2 antihistamines: Ranitidine 1
  3. Corticosteroids (may help prevent biphasic reactions, though evidence is limited)

    • Prednisone daily for 2-3 days 1
  4. Supportive care

    • Supplemental oxygen if needed
    • IV fluids for hypotension
    • Place patient in recumbent position with lower extremities elevated if tolerated 1

Post-Treatment Management

Observation Period

  • All patients who receive epinephrine should be transferred to an emergency facility 1
  • Observe for 4-6 hours after successful treatment 1
  • Longer observation or hospital admission for severe or refractory symptoms 1
  • Monitor for biphasic reactions (can occur up to 72 hours later) 1

Discharge Plan After Anaphylaxis

  1. Provide emergency action plan 1, 5
  2. Prescribe epinephrine autoinjector (2 doses) 1, 4, 6
  3. Continue medications for 2-3 days 1
    • H1 antihistamine (consider switching to non-sedating option) 3
    • H2 antihistamine
    • Corticosteroid
  4. Schedule follow-up with primary care provider and consider referral to allergist/immunologist 1
  5. Recommend medical identification jewelry for patients at risk 1

High-Risk Patients

Special attention should be given to patients with:

  • Previous history of anaphylaxis
  • Asthma (especially poorly controlled)
  • Known allergy to peanuts, tree nuts, fish, or shellfish
  • Mast cell disorders
  • Cardiovascular disease 1, 7

Common Pitfalls to Avoid

  • Delaying epinephrine administration - this is associated with increased mortality 1, 4, 8
  • Using antihistamines alone for anaphylaxis - they are not sufficient and may delay proper treatment 1, 3
  • Failing to prescribe autoinjectors - patients at risk should carry two doses at all times 1, 6
  • Inadequate observation time - patients should be monitored for potential biphasic reactions 1
  • Insufficient patient education - patients need clear instructions on allergen avoidance and when/how to use epinephrine 1, 5

Remember that there are no absolute contraindications to epinephrine in anaphylaxis, as the risk of death from untreated anaphylaxis outweighs potential adverse effects of epinephrine 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Allergic Reaction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine in the Management of Anaphylaxis.

The journal of allergy and clinical immunology. In practice, 2020

Research

Self-injectable epinephrine for allergic emergencies.

The Journal of emergency medicine, 2009

Research

Anaphylaxis: Recognition and Management.

American family physician, 2020

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.